Vukovic, M.; Chamlati, J.M.; Hennenlotter, J.; Todenhöfer, T.; Lütfrenk, T.; Jersinovic, S.; Tsaur, I.; Stenzl, A.; Rausch, S.
Interleukin-1β/Interleukin (IL)-1-Receptor-Antagonist (IL1-RA) Axis in Invasive Bladder Cancer—An Exploratory Analysis of Clinical and Tumor Biological Significance. Int. J. Mol. Sci. 2024, 25, 2447.
https://doi.org/10.3390/ijms25042447
AMA Style
Vukovic M, Chamlati JM, Hennenlotter J, Todenhöfer T, Lütfrenk T, Jersinovic S, Tsaur I, Stenzl A, Rausch S.
Interleukin-1β/Interleukin (IL)-1-Receptor-Antagonist (IL1-RA) Axis in Invasive Bladder Cancer—An Exploratory Analysis of Clinical and Tumor Biological Significance. International Journal of Molecular Sciences. 2024; 25(4):2447.
https://doi.org/10.3390/ijms25042447
Chicago/Turabian Style
Vukovic, Marko, Jorge M. Chamlati, Jörg Hennenlotter, Tilman Todenhöfer, Thomas Lütfrenk, Sebastian Jersinovic, Igor Tsaur, Arnulf Stenzl, and Steffen Rausch.
2024. "Interleukin-1β/Interleukin (IL)-1-Receptor-Antagonist (IL1-RA) Axis in Invasive Bladder Cancer—An Exploratory Analysis of Clinical and Tumor Biological Significance" International Journal of Molecular Sciences 25, no. 4: 2447.
https://doi.org/10.3390/ijms25042447
APA Style
Vukovic, M., Chamlati, J. M., Hennenlotter, J., Todenhöfer, T., Lütfrenk, T., Jersinovic, S., Tsaur, I., Stenzl, A., & Rausch, S.
(2024). Interleukin-1β/Interleukin (IL)-1-Receptor-Antagonist (IL1-RA) Axis in Invasive Bladder Cancer—An Exploratory Analysis of Clinical and Tumor Biological Significance. International Journal of Molecular Sciences, 25(4), 2447.
https://doi.org/10.3390/ijms25042447
